- Home
- FRGE vs NBTX Comparison
FRGE vs NBTX Comparison
Compare FRGE & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- NBTX
- Stock Information
- Founded
- FRGE 2014
- NBTX 2003
- Country
- FRGE United States
- NBTX France
- Employees
- FRGE N/A
- NBTX N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- NBTX Health Care
- Exchange
- FRGE Nasdaq
- NBTX Nasdaq
- Market Cap
- FRGE 207.0M
- NBTX 201.9M
- IPO Year
- FRGE N/A
- NBTX 2020
- Fundamental
- Price
- FRGE $0.96
- NBTX $3.83
- Analyst Decision
- FRGE Strong Buy
- NBTX Strong Buy
- Analyst Count
- FRGE 3
- NBTX 2
- Target Price
- FRGE $4.50
- NBTX $11.50
- AVG Volume (30 Days)
- FRGE 632.6K
- NBTX 8.8K
- Earning Date
- FRGE 11-06-2024
- NBTX 11-26-2024
- Dividend Yield
- FRGE N/A
- NBTX N/A
- EPS Growth
- FRGE N/A
- NBTX N/A
- EPS
- FRGE N/A
- NBTX N/A
- Revenue
- FRGE $79,799,000.00
- NBTX $45,220,186.00
- Revenue This Year
- FRGE $19.18
- NBTX N/A
- Revenue Next Year
- FRGE $39.61
- NBTX N/A
- P/E Ratio
- FRGE N/A
- NBTX N/A
- Revenue Growth
- FRGE 18.08
- NBTX 526.17
- 52 Week Low
- FRGE $0.80
- NBTX $3.57
- 52 Week High
- FRGE $4.02
- NBTX $8.96
- Technical
- Relative Strength Index (RSI)
- FRGE 40.41
- NBTX 38.67
- Support Level
- FRGE $0.80
- NBTX $3.57
- Resistance Level
- FRGE $1.38
- NBTX $4.11
- Average True Range (ATR)
- FRGE 0.09
- NBTX 0.28
- MACD
- FRGE -0.01
- NBTX -0.00
- Stochastic Oscillator
- FRGE 27.21
- NBTX 26.31
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The Company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.